← SynDRA
TENOFOVIR ALAFENAMIDE
SynDRA canonical compound SYN0033269 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | GAG-POL |
|---|
| Mechanism of action | hiv gag inhibitor |
|---|
| Indication | human immunodeficiency virus (hiv-1) |
|---|
| Disease area | Infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- hiv gag inhibitor
- nucleoside reverse transcriptase inhibitor
- Inhibitor
Drug classes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- GS-7340
- tenofovir alagenamide
- tenofovir alafenamide fumarate
- Tenofovir alafenamida
- Gs-7340
- GS-734003
- Vemlidy
- GS 7340
- EL9943AG5J
- CHEBI:90926
- TFV Alafenamide
- RefChem:56250
- DTXCID401386833
- MFCD23843796
- UNII-EL9943AG5J
- GS7340
- Tenofovir Alafenamide [USAN]
- Tenofovir Alafenamide (GS-7340)
- C21H29N6O5P
- GS-7339
- Tenofovir Alafenamide [USAN:INN]
- UNII-J4414G3BUK
- orb1305529
- orb3141355
- SCHEMBL3107149
- GS-7340 Tenofovir alafenamide
- SCHEMBL29351625
- GTPL14054
- EX-A610
- GS-7340; Tenofovir alafenamide
- LDEKQSIMHVQZJK-CAQYMETFSA-N
- Tenofovir alafenamide (free base)
- BDBM689130
- GLXC-07489
- Tenofovir alafenamide (USAN/INN)
- TENOFOVIR ALAFENAMIDE [MI]
- US12049474, Compound TAF
Reported adverse events
- Fanconi syndrome
- Hepatomegaly
- Lactic acidosis
- Nausea
- Angioedema
- Fatigue
- Headache
- Hepatitis B
- Rash
- Suicidal ideation
- Dizziness
- Flatulence
Look up TENOFOVIR ALAFENAMIDE in the interactive SynDRA portal →